Patient Dosing Resumes in Alzheimer’s Clinical Trial
2022年1月21日 - 3:48AM
AllPennyStocks.com
Treatments for Alzheimer’s continue to be lacking in the
clinical community. A drug repurposing by the pharmaceutical
company has the potential to be an effective treatment for mild
to...
To read the full story on AllPennyStocks.com, click
here.
Intelgenx Technologies (TSX:IGX)
過去 株価チャート
から 5 2024 まで 6 2024
Intelgenx Technologies (TSX:IGX)
過去 株価チャート
から 6 2023 まで 6 2024
